Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
F-Star Therapeutics Inc
(NQ:
FSTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about F-Star Therapeutics Inc
< Previous
1
2
3
4
Next >
Week In Review: Sino Biopharma Acquires F-Star For $161 Million After US Approval
March 11, 2023
Sino Biopharma was approved to close its $161 million all-cash acquisition of F-Star. The purchase didn't look like would happen after it was held up for nine months by the US government’s Committee on...
Via
Talk Markets
invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
March 08, 2023
From
invoX Pharma
Via
Business Wire
Why F-Star Therapeutics Shares Are Moving Higher
March 07, 2023
F-Star Therapeutics Inc (NASDAQ: FSTX) shares are trading higher Tuesday after the company announced clearance for the proposed acquisition by invoX Ph
Via
Benzinga
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
March 07, 2023
Parties expect the merger to be completed promptly following the successful completion of the ongoing Tender Offer
From
F-star Therapeutics, Inc.
Via
GlobeNewswire
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 07, 2023
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 01, 2023
Via
Benzinga
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
January 27, 2023
Gainers Freightos Limited (NASDAQ: CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I...
Via
Benzinga
invoX Pharma and F-star Therapeutics issue Joint Statement
January 26, 2023
From
F-star Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
January 26, 2023
Via
Benzinga
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 26, 2023
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 30, 2022
Via
Benzinga
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
US Stocks Open Lower; Dow Drops 250 Points
December 30, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 30, 2022
Via
Benzinga
Why F-Star Therapeutics Stock Is Getting Obliterated During Thursday's Session
December 29, 2022
F-Star Therapeutics Inc (NASDAQ: FSTX) shares are trading lower by 39.94% to $4.12 Thursday afternoon after the Committee on Foreign Investment issued an interim order preventing the closing of the...
Via
Benzinga
Dow Rises Over 1%; Cal-Maine Foods Shares Plummet
December 29, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 250 points on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 29, 2022
Via
Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
December 29, 2022
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
Via
Benzinga
Nasdaq Jumps Over 250 Points; Crude Oil Down 1%
December 29, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones climbing around 400 points on Thursday.
Via
Benzinga
Dow Surges 250 Points; Jobless Claims Rise To 225,000
December 29, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday.
Via
Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
December 21, 2022
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 21, 2022
Via
Benzinga
Dow Surges 300 Points; US Current Account Deficit Narrows In Third Quarter
December 21, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 21, 2022
Via
Benzinga
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress
December 06, 2022
FS222 demonstrated early antitumor activity with one complete response and six disease stabilizations in patients with advanced solid tumors
From
F-star Therapeutics, Inc.
Via
GlobeNewswire
F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
November 07, 2022
From
F-star Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.